Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Elixir of Age: Liz Parrish’s Deep Dive into Gene Therapy and Lifespan Leaps - Episode 218

Elixir of Age: Liz Parrish’s Deep Dive into Gene Therapy and Lifespan Leaps - Episode 218

FromGladden Longevity Podcast -- formerly Living Beyond 120


Elixir of Age: Liz Parrish’s Deep Dive into Gene Therapy and Lifespan Leaps - Episode 218

FromGladden Longevity Podcast -- formerly Living Beyond 120

ratings:
Length:
46 minutes
Released:
Jan 18, 2024
Format:
Podcast episode

Description

Welcome to another episode of the Gladden Longevity Podcast with Dr. Jeffrey Gladden, Steve Reiter, and today’s guest, Liz Parrish! Elizabeth Parrish is the Founder and CEO of BioViva, a company committed to extending healthy lifespans using cell technologies. Liz is a humanitarian, entrepreneur, innovator, podcaster, and a leading voice for genetic cures.  As a strong proponent of progress and education for advancing regenerative medicine modalities, she serves as a motivational speaker to the public at large for the life sciences. She is actively involved in international educational media outreach. This podcast explores gene therapy's potential to combat age-related diseases, aiming for accessibility and affordability. We highlight the reversal of aging in lab animals and argue against regulatory delays, advocating for prompt access to life-saving interventions. Advancing anti-aging gene therapies saves lives, reduces healthcare costs, and minimizes human suffering. We stress the importance of public awareness and individuals' choice in adopting transformative medical approaches, challenging regulatory obstacles for a healthier future.   Steve shares how he is enjoying the nice weather. (2:55) Dr. Gladden started doing infinity walking. (3:25) Liz talks about learning movement and swimming with her eyes closed. (05:11) Liz says what they look for are some genes that can capture some of their functions. (7:10) Dr. Gladden says it is doing something similar to Liz. (09:14) Liz shares how they chose genes and the type of results they are seeing. (12:00) Liz speaks about a company that does not treat patients but connects them to doctors. (15:00) Liz highlights how her son was diagnosed with diabetes. (16:08) Liz talks about how there is only one approved cell therapy in the United States. (16:56) Liz discusses about a gene that has already been used in non-human primates. (19:08) In 2015, Liz took some gene therapies to treat biological aging. (21:34) Liz describes the effects of the treatment on her telomeres (24:25). Positive impact of gene therapies on health. (25:07) The short telomeres are the most critical, and improving them can benefit health. (27:10) Liz did her gene therapy in Columbia. (30:29) Gene therapies in the US are expensive but cheaper in other places. (32:30) Atala creates a body on a chip for drug testing. (36:02) Dr. Gladden believes we could crack the code on many things faster by using AI as a tool. (38:35) Liz is pushing people towards understanding more about medical tourism. (40:35) Liz looks forward to seeing medical tourism overcome clinical trials. (45:10) Exercise is important for your whole body. (48:45) We live in the greatest time in human history. (50:50)   To know more about Liz: Website: https://bioviva-science.com/ Facebook: https://www.facebook.com/BiovivaSciences LinkedIn: https://www.linkedin.com/company/biovivasciences Twitter/X: twitter.com/BioVivaScience Email: info@bioviva-science.com Youtube: https://www.youtube.com/channel/UCaBq8hEExcUN6mtKMEuBvMQ
Released:
Jan 18, 2024
Format:
Podcast episode

Titles in the series (100)

On this podcast focused on health and human longevity, Dr. Jeffrey R. Gladden, MD, FACC examines the latest scientific research, technology, and bio-hacks to uncover the truth about the human body’s potential for extending both life and health span well past what most people accept as biological facts.